DHI vs EBS · P/E 9.6, rev $34.25B vs rev $1.04B
DR Horton Inc (DHI) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DHI and EBS stock pages for the full models.
Not investment advice.